天美传媒

Abstract

Insulin therapy is fundamental in managing diabetes mellitus, yet traditional delivery methods present challenges such as dosing inaccuracies, adherence issues, and risk of hypoglycemia. Smart implantable devices offer a promising solution by providing continuous monitoring of blood glucose levels and on-demand insulin release. This article explores the emerging field of smart implants for insulin delivery, highlighting technological advancements, clinical implications, and future directions. Miniaturized devices equipped with glucose sensors and insulin actuators enable precise control of blood glucose levels while minimizing patient burden. Closed-loop systems integrate continuous glucose monitoring with automated insulin delivery algorithms, offering real-time adjustments based on glucose levels. Biocompatible materials ensure long-term functionality and safety of smart implants. Clinical benefits include improved glycemic control, enhanced patient satisfaction, and prevention of long-term complications. Future research should focus on long-term safety and efficacy studies, integration with artificial intelligence, and improving accessibility and affordability. Smart implants have the potential to revolutionize insulin therapy and improve outcomes for individuals living with diabetes.